Thu Oct 23 18:04:18 SGT 2014  
HEPATITIS
B
    Hepatitis B, Jamaica
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Hepatitis B, Jamaica

Summary

Hepatitis B, Jamaica @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Jamaica - Private and confidential service.

Keywords: Hepatitis B Jamaica, Jamaica Hepatitis B, Hepatitis B.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Jamaica
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference


Latest News

SummonChimera infers integrated viral genomes with nucleotide precision from NGS data
Wed, 22 Oct 2014 00:00:00 +0100 | Epidemiologic Perspectives and Innovations
Conclusions:

[Articles] HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010–12: a retrospective observational cohort study
Tue, 21 Oct 2014 06:15:31 +0100 | The Lancet Infectious Diseases
Screening for viral hepatitis is important in individuals diagnosed as HIV positive. Effective management for viral hepatitis should be integrated into HIV treatment programmes. Long-term data are needed about the effect of hepatitis co-infection on HIV disease progression. (Source: The Lancet Infectious Diseases)

[Comment] Hepatitis virus and HIV interactions
Tue, 21 Oct 2014 06:15:01 +0100 | The Lancet Infectious Diseases
Because of shared routes of transmission, 5–25% of the 34 million people with HIV worldwide are co-infected with either hepatitis B virus (HBV), hepatitis C virus (HCV), or both, with the highest number of co-infections in low-income countries. The negative effect of HIV infection on the progression of HBV and HCV infection is well established, with high rates of viral persistence, higher hepatitis viral load, and a more rapid progression to liver fibrosis and hepatocellular carcinoma in HIV-positive patients. (Source: The Lancet Infectious Diseases)

The Immunobiology of Hepatitis B Virus Infection
Mon, 20 Oct 2014 00:00:00 +0100 | Hepatology Research
Abstract

Vaccines and MS
Sun, 19 Oct 2014 23:00:00 +0100 | Multiple Sclerosis Trust
A study found no association between hepatitis B and human papillomavirus (HPV) vaccines and an increased risk of MS up to three years after vaccination.

Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.
Fri, 17 Oct 2014 00:00:00 +0100 | The British Journal of Nutrition
Authors: Fiorino S, Bacchi-Reggiani L, Sabbatani S, Grizzi F, di Tommaso L, Masetti M, Fornelli A, Bondi A, de Biase D, Visani M, Cuppini A, Jovine E, Pession A

Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta‐analysis
Thu, 16 Oct 2014 00:00:00 +0100 | Journal of Gastroenterology and Hepatology
ConclusionsThe resistance mutations occurred frequently in untreated CHB patients, especially in China. The lamivudine resistance had the highest natural prevalence rate, while other nucleos(t)ide analogues showed rarely spontaneous resistance. Detecting the spontaneous resistance mutations will benefit the clinical management of CHB patients. (Source: Journal of Gastroenterology and Hepatology)

Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion
Thu, 16 Oct 2014 00:00:00 +0100 | Journal of Clinical Pathology
Conclusions

Measuring Chronic Liver Disease Mortality Using an Expanded Cause of Death Definition and Medical Records in Connecticut, 2004
Thu, 16 Oct 2014 00:00:00 +0100 | Hepatology Research
ConclusionAn expanded CLD mortality case definition that incorporates multiple causes of death and additional CLD‐related conditions will better estimate CLD mortality. (Source: Hepatology Research)

The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long‐term nucleos(t)ide analogue therapy
Tue, 14 Oct 2014 09:17:46 +0100 | Alimentary Pharmacology and Therapeutics
ConclusionsIn this Canadian study of nucleos(t)ide analogues‐treated patients with chronic hepatitis B, the incidence of HCC was lower than expected, suggesting that NA reduce the risk of chronic hepatitis B‐related HCC. (Source: Alimentary Pharmacology and Therapeutics)